| Amy Brooke Jernigan, LPC | |
|
605 W Oxford Ave, Enid, OK 73701-1208 | |
| (580) 233-7220 | |
| (580) 237-7550 |
| Full Name | Amy Brooke Jernigan |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 605 W Oxford Ave, Enid, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013140102 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | 4052 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amy Brooke Jernigan, LPC 605 W Oxford Ave, Enid, OK 73701-1208 Ph: (580) 233-7220 | Amy Brooke Jernigan, LPC 605 W Oxford Ave, Enid, OK 73701-1208 Ph: (580) 233-7220 |
News Archive
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome, and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its wholly-owned subsidiary, Biospherics Incorporated, has signed a license agreement with the University of Kentucky Research Foundation (UKRF).
As we age, most of us come to depend on prescription drugs to help us live healthier, longer lives. But the very medications that we count on for better health could also land us in the hospital.
Gamida Cell announced today the publication of an article evaluating carlecortemcel-l, the generic name of what is widely known as "StemEx", as a therapy for blood cancers such as leukemia and lymphoma. The article, carlecortemcel-l, an ex vivo expanded umbilical cord blood cell graft for allogeneic transplantation, written by Dr. Ka Wah Chan and Dr. Demetrios Petropoulos, will be published in the November 2009 issue of Expert Opinion on Biological Therapy.
Discovery Laboratories, Inc., announces the publication of results from its previously-conducted Phase 2a feasibility study of Aerosurf, the Company's aerosolized KL4 surfactant, for the prevention of respiratory distress syndrome in premature infants, in the May 2010 issue of the Journal of Aerosol Medicine and Pulmonary Drug Delivery in the study titled "An Open Label, Pilot Study of Aerosurf Combined with nCPAP to Prevent RDS in Preterm Neonates".
› Verified 1 days ago
James Stilley, Counselor Medicare: Not Enrolled in Medicare Practice Location: 702 N Grand St, Enid, OK 73701 Phone: 580-234-3791 Fax: 580-237-7711 | |
Brady Dixon, Counselor Medicare: Not Enrolled in Medicare Practice Location: 702 N Grand St, Enid, OK 73701 Phone: 580-234-3791 Fax: 580-237-7711 | |
Mr. Mark Alan Blanchard, BS, BHRS Counselor Medicare: Not Enrolled in Medicare Practice Location: 1625 W Owen K Garriott Rd, Ste F, Enid, OK 73703 Phone: 580-242-4673 Fax: 580-242-4679 | |
Ramona Vernita Nazario, Counselor Medicare: Not Enrolled in Medicare Practice Location: 706 Bryan Dr, Enid, OK 73701 Phone: 580-234-2501 Fax: 580-213-3133 | |
Alexsandra D Stevens, LPC CANDIDATE Counselor Medicare: Not Enrolled in Medicare Practice Location: 230 W Maple Ave, Enid, OK 73701 Phone: 580-242-5544 | |
Mrs. Linda Peck, Counselor Medicare: Not Enrolled in Medicare Practice Location: 230 W Maple Ave, Enid, OK 73701 Phone: 580-242-5544 Fax: 580-233-8905 |